US equities |
MU $878.84 ▼-5.63% NVDA $214.13 ▼-1.43% TSLA $354.72 ▼-2.13% AAPL $343.46 ▲+0.43% META $709.33 ▼-3.72% MSFT $529.05 ▼-1.93% SPCX $146.03 ▼-1.74% AMD $528.75 ▼-5.95%
FinancialContent

HilleVax, Inc. - Common Stock (NQ:HLVX)

2.090 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.090
Bid (Size) 2.090 (50)
Ask (Size) 2.110 (10)
Prev. Close 2.090
Today's Range 2.090 - 2.090
52wk Range 2.090 - 2.090
Shares Outstanding 39,200,174
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
HilleVax Stockholders Received $1.95 Per Share in Cash Plus a Contingent Value Right 
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
HILLEVAX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX
From Kahn Swick & Foti, LLC
Via GlobeNewswire

Performance

More News

Read More
News headline image
(HLVX) - Analyzing HilleVax's Short Interest ↗
Via Benzinga
News headline image
Shareholder Alert: The Ademi Firm Investigates Whether HilleVax, Inc. Is Obtaining a Fair Price for Its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
News headline image
HilleVax Reports Second Quarter 2025 Financial Results
From HilleVax, Inc.
Via GlobeNewswire
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
Via Chartmill
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HLVX, BSGM, TTNP on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
HILLEVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq – HLVX), Steelcase Inc. (NYSE – SCS), LAVA Therapeutics N.V. (Nasdaq – LVTX), Arcadia Biosciences, Inc. (Nasdaq – RKDA)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
HLVX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of HilleVax, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Kosmos Energy Posts Downbeat Q2 Results, Joins HilleVax And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire
News headline image
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire
News headline image
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire
News headline image
HLVX Stock Earnings: HilleVax Misses EPS for Q2 2024 ↗
Via InvestorPlace
News headline image
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire
News headline image
HilleVax Announces Reduction in Force
From HilleVax, Inc.
Via GlobeNewswire
News headline image
HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Gold Falls Over 1%; HilleVax Shares Plunge ↗
Via Benzinga
News headline image
Stocks Hold Steady, Small Caps Rise, French Equities Slip After Surprise Win By Left-Wing Bloc: What's Driving Markets Monday? ↗
Via Benzinga
News headline image
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Via Benzinga
News headline image
GRFS Stock Alert: Grifols Pops 20% on Takeover Interest ↗
Via InvestorPlace

Frequently Asked Questions

Is HilleVax, Inc. - Common Stock publicly traded?
Yes, HilleVax, Inc. - Common Stock is publicly traded.
What exchange does HilleVax, Inc. - Common Stock trade on?
HilleVax, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for HilleVax, Inc. - Common Stock?
The ticker symbol for HilleVax, Inc. - Common Stock is HLVX on the Nasdaq Stock Market
What is the current price of HilleVax, Inc. - Common Stock?
The current price of HilleVax, Inc. - Common Stock is 2.090
When was HilleVax, Inc. - Common Stock last traded?
The last trade of HilleVax, Inc. - Common Stock was at 09/16/25 04:00 PM ET
What is the market capitalization of HilleVax, Inc. - Common Stock?
The market capitalization of HilleVax, Inc. - Common Stock is 81.93M
How many shares of HilleVax, Inc. - Common Stock are outstanding?
HilleVax, Inc. - Common Stock has 82M shares outstanding.